Chemoinformaics analysis of Methyl 2,5-octadecadiynoate
| Molecular Weight | 290.447 | nRot | 10 |
| Heavy Atom Molecular Weight | 260.207 | nRig | 3 |
| Exact Molecular Weight | 290.225 | nRing | 0 |
| Solubility: LogS | -6.53 | nHRing | 0 |
| Solubility: LogP | 6.707 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 53.3378 |
| nHD | 0 | BPOL | 32.7002 |
| QED | 0.248 |
| Synth | 2.771 |
| Natural Product Likeliness | 0.917 |
| NR-PPAR-gamma | 0.75 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.989 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.612 |
| MDCK | 0.0000138 |
| BBB | 0.044 |
| PPB | 0.985154 |
| VDSS | 2.293 |
| FU | 0.00680325 |
| CYP1A2-inh | 0.618 |
| CYP1A2-sub | 0.21 |
| CYP2c19-inh | 0.812 |
| CYP2c19-sub | 0.328 |
| CYP2c9-inh | 0.566 |
| CYP2c9-sub | 0.984 |
| CYP2d6-inh | 0.185 |
| CYP2d6-sub | 0.084 |
| CYP3a4-inh | 0.475 |
| CYP3a4-sub | 0.06 |
| CL | 7.319 |
| T12 | 0.084 |
| hERG | 0.002 |
| Ames | 0.084 |
| ROA | 0.061 |
| SkinSen | 0.976 |
| Carcinogencity | 0.511 |
| EI | 0.956 |
| Respiratory | 0.962 |
| NR-Aromatase | 0.166 |
| Antiviral | No |
| Prediction | 0.577213 |